New Mid-Size Pharma Client and Continuation of Existing Contracts

The year 2014 was a good one for Scalable Life Sciences with the acquisition of a new mid-size pharma client and the continuation of existing contracts with larger and smaller firms.

Scalable supported an existing client in the areas of market access, public affairs and product communications. The company worked with another client on corporate communications and public affairs. The work for one of the other clients focused on corporate communications, product communications, the improvement of its interaction with Key Opinion Leaders and its partnering with large pharma. A conference organizer and an international organization were also part of the client group.

Corporate Communications, Investor Relations and Public Affairs for Life Sciences